IRIS
MURINEDDU, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.113
AS - Asia 3.143
SA - Sud America 2.145
EU - Europa 1.802
AF - Africa 134
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 13.362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.006
BR - Brasile 1.888
SG - Singapore 1.207
CN - Cina 1.015
UA - Ucraina 688
DE - Germania 285
HK - Hong Kong 273
IT - Italia 240
VN - Vietnam 153
SE - Svezia 147
FI - Finlandia 120
TR - Turchia 118
AR - Argentina 104
GB - Regno Unito 81
BD - Bangladesh 63
FR - Francia 55
IN - India 53
IQ - Iraq 49
EC - Ecuador 40
ZA - Sudafrica 40
CA - Canada 37
RU - Federazione Russa 37
BE - Belgio 31
MX - Messico 31
MA - Marocco 29
UZ - Uzbekistan 28
CO - Colombia 27
VE - Venezuela 26
JP - Giappone 24
ID - Indonesia 21
KE - Kenya 21
PK - Pakistan 21
KR - Corea 19
PL - Polonia 17
CL - Cile 16
PY - Paraguay 16
AT - Austria 13
AU - Australia 13
CZ - Repubblica Ceca 13
ES - Italia 13
TN - Tunisia 13
JO - Giordania 12
PE - Perù 12
DO - Repubblica Dominicana 11
UY - Uruguay 10
AL - Albania 9
KZ - Kazakistan 9
NL - Olanda 9
EU - Europa 8
IR - Iran 8
AZ - Azerbaigian 7
JM - Giamaica 7
LB - Libano 7
NP - Nepal 7
RO - Romania 7
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
BH - Bahrain 5
BO - Bolivia 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
BG - Bulgaria 4
PA - Panama 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BY - Bielorussia 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
LT - Lituania 3
NG - Nigeria 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
IE - Irlanda 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
GN - Guinea 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GY - Guiana 1
HN - Honduras 1
Totale 13.345
Salva come PNG Salva come JPEG
Città #
Dallas 2.760
Chandler 675
Singapore 595
Jacksonville 419
Hong Kong 273
Princeton 238
Dearborn 216
Beijing 207
Nanjing 192
Ashburn 171
New York 116
Ann Arbor 109
São Paulo 108
Wilmington 106
Shanghai 78
Izmir 76
Rio de Janeiro 70
Ho Chi Minh City 68
Sassari 64
Los Angeles 57
Nanchang 57
Shenyang 56
Belo Horizonte 52
Woodbridge 46
Brasília 43
Hebei 43
Tianjin 41
Changsha 39
Santa Clara 33
Jiaxing 31
Brussels 30
Tashkent 28
Guarulhos 27
Hanoi 27
Porto Alegre 24
Baghdad 23
Curitiba 23
Tokyo 23
Boardman 22
Buffalo 22
Johannesburg 22
Kunming 22
Helsinki 21
Rome 21
Nairobi 20
Andover 19
Ningbo 19
Santo André 19
Seoul 19
Buenos Aires 18
Jinan 18
Sorocaba 18
Campinas 17
Caxias do Sul 17
Columbus 17
Guangzhou 17
Ribeirão Preto 17
San Francisco 17
San Mateo 17
Hangzhou 16
Montreal 16
Mountain View 16
Munich 16
Norwalk 16
The Dalles 16
Guayaquil 15
Quito 15
Istanbul 14
Warsaw 14
Contagem 13
Denver 13
Dhaka 13
Salvador 13
Toronto 13
Amman 12
Bogotá 12
Brooklyn 12
Casablanca 12
Fortaleza 12
Frankfurt am Main 12
Goiânia 12
Manaus 12
Osasco 12
Recife 12
São José do Rio Preto 12
Taizhou 12
Zhengzhou 12
Asunción 11
Council Bluffs 11
Houston 11
London 11
Monmouth Junction 11
Stockholm 11
Augusta 10
Cagliari 10
Chicago 10
Franca 10
Joinville 10
Orem 10
São José dos Campos 10
Totale 8.154
Salva come PNG Salva come JPEG
Nome #
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 444
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 272
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 231
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 223
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 221
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and biological evaluation 195
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 166
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 161
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 153
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 153
Composti farmaceutici 147
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 144
Approcci terapeutici contro il cancro. Tradizione e innovazione. 144
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 139
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 132
Oxadiazoles having antiproliferative activity 131
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 127
CAPITOLO 41. Antielmintici 127
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 126
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 125
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 125
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 123
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 123
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 123
A survey of Recent Patents on CB2 Agonists in the Management of Pain 123
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 122
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 121
Antiviral activity of benzotriazole based derivatives 120
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 119
Pharmaceutical compounds 118
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 117
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 116
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 114
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 112
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 112
Chimica farmaceutica 110
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 109
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 109
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 108
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 108
Pharmaceutical Compounds 107
The organic chemistry of drug design and drug action 107
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 106
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 106
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 106
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 105
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 104
Chromophore-modified bis-benzo[g]indolecarboxamides: synthesis and citotoxicity of bis-benzo[g]indazole-3-carboxamides and related compounds 103
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 102
Diazacyclic compounds having affinity for opioid receptors 100
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 99
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 99
Pharmaceutical compounds 98
Pharmaceutical Compounds 98
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 97
Oxadiazoles having anti proliferative activity 97
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 97
Novel diazabicycloalkane delta opioid agonists 97
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 96
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 96
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 96
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 96
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 95
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 95
Pharmaceutical compounds 94
Synthesis and biological evaluation of diazabiciclo[3.3.1]nonanes with a thiother bridge 93
Synthesis of biologically active bridged diazabicycloheptanes 93
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 92
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 91
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 90
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 90
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 89
Pharmaceutical compounds 89
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 88
Chimica farmaceutica. Con e-book 88
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 87
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 87
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 87
Pharmaceutical compounds 87
Pyrazolo-naphthyridines: Design and Synthesis of potential CB-ligands 86
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 86
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 86
Pirazoli triciclici: sintesi e valutazione biologica di ligandi per i recettori cannabinoidei con struttura diidroindenopirazolica contenenti differenti sostituenti carbossammidici 85
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 83
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors 83
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori µ degli oppioidi 83
Synthesis, pharmacological evaluation and docking studies of pirrole structure-based CB2 receptor antagonists. 82
Ossadiazoli ad attività antiproliferativa 82
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 82
New tricyclic pyrazole derivatives as CB1 antagonists having improved activity towards food intake and weight control 81
Pharmaceutical compounds 81
Pirazoli Triciclichi. Sintesi e valutazione biologica di ligandi per i recettori cannabinoidi con struttura diidroindenopirazolica contenente differenti sostituenti carbossamidici 81
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 80
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 80
Design, Synthesis and preliminary biological data of new ligands for neuronal nicotinic acetylcholine receptors 80
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 79
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 79
Sintesi di nuovi leganti chirali dipiridilmetanici e loro applicazione nella sostituzione allilica palladio-catalizzata 78
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 78
Oxadiazoles having antiproliferative activity 77
Totale 11.352
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.475
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021544 0 0 0 0 0 32 124 23 128 135 82 20
2021/2022572 67 6 9 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/20253.579 20 20 186 59 124 117 277 583 1.351 573 161 108
2025/20264.776 222 1.544 1.679 875 387 69 0 0 0 0 0 0
Totale 13.483